April 10, 2006
The United States Anti-Doping Agency (USADA) announced today that Jermell Pennie of Arlington, Texas, an athlete in the sport of Paralympic basketball, has accepted a two-year suspension after his sample collected November 23, 2005 as part of the USADA Out-of-Competition Testing Program tested positive for the prohibited substance formestane (4-hydroxyandrostendione).
Formestane is classified as an agent with anti-estrogenic activity (aromatase inhibitors) under the rules of the International Paralympic Committee (IPC), the international governing body for Paralympic sport, and USADA, both of which have adopted the World Anti-Doping Agency’s Prohibited List.
Pennie’s two-year suspension begins on March 16, 2006, the date he accepted the sanction. Additionally, Pennie forfeits all competitive results, including any medals, points and prizes, obtained subsequent to November 23, 2005. U.S. Paralympics, the national governing body for Paralympic sport in the United States, will carry out the sanction.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and education programs.